Vidiia Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $845K

  • Investors
  • 7

Vidiia General Information

Description

Developer of molecular testing and diagnostic platform designed to address challenges in infectious disease control on a global scale. The company's tool leverages artificial intelligence (AI) to identify and develop new assays, translating academic research into a real-world, cost-effective diagnostic system, enabling healthcare providers to conduct rapid, on-site testing for diseases, improving patient care and accessibility.

Contact Information

Website
www.vidiia.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 71-75 Shelton Street, Covent Garden
  • London WC2H 9JQ
  • England, United Kingdom
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Monitoring Equipment
Corporate Office
  • 71-75 Shelton Street, Covent Garden
  • London WC2H 9JQ
  • England, United Kingdom

Vidiia Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vidiia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 28-Aug-2024 $845K Completed Generating Revenue
3. Accelerator/Incubator 28-Aug-2024 Completed Generating Revenue
2. Grant 01-Jan-2019 $16.7K Completed Generating Revenue
1. University Spin-Out Completed Generating Revenue
To view Vidiia’s complete valuation and funding history, request access »

Vidiia Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Shares
Ordinary
Ordinary
Ordinary
Ordinary 877 $0.000258 $73.58 $73.58 1x $73.58 0.54%
Ordinary 3,100 $0.000258 $83.26 $83.26 1x $83.26 1.9%
To view Vidiia’s complete cap table history, request access »

Vidiia Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vidiia Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
819 Capital Partners Venture Capital Minority
Brunel University Endowment Limited Partner Minority
University of Surrey University Minority
Veterinary Health Innovation Engine Accelerator/Incubator
Innovate UK Government
You’re viewing 5 of 7 investors. Get the full list »

Vidiia FAQs

  • When was Vidiia founded?

    Vidiia was founded in 2020.

  • Where is Vidiia headquartered?

    Vidiia is headquartered in London, United Kingdom.

  • What is the size of Vidiia?

    Vidiia has 6 total employees.

  • What industry is Vidiia in?

    Vidiia’s primary industry is Discovery Tools (Healthcare).

  • Is Vidiia a private or public company?

    Vidiia is a Private company.

  • What is the current valuation of Vidiia?

    The current valuation of Vidiia is .

  • What is Vidiia’s current revenue?

    The current revenue for Vidiia is .

  • How much funding has Vidiia raised over time?

    Vidiia has raised $845K.

  • Who are Vidiia’s investors?

    819 Capital Partners, Brunel University Endowment, University of Surrey, Veterinary Health Innovation Engine, and Innovate UK are 5 of 7 investors who have invested in Vidiia.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process